Conference Program.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, p. 1, doi. 10.1038/sj.cgt.7700262
- Publication type:
- Article
Works matching IS 09291903 AND DT 2000 AND VI 7
Results: 204
1
2
Conference Abstracts.
- Published in:
- 2000
- Publication type:
- Abstract
3
Index of Authors.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, p. S30, doi. 10.1038/sj.cgt.7700296
- Publication type:
- Article
4
Towards the optimal vector for prostate cancer gene therapy; a CaP CURE meeting report.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1507, doi. 10.1038/sj.cgt.7700253
- By:
- Publication type:
- Article
5
Combined suicide and granulocyte–macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1519, doi. 10.1038/sj.cgt.7700259
- By:
- Publication type:
- Article
6
An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1575, doi. 10.1038/sj.cgt.7700261
- By:
- Publication type:
- Article
7
Antitumor effects of the combination therapy with TNF-α gene–modified tumor cells and interleukin 12 in a melanoma model in mice.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1581, doi. 10.1038/sj.cgt.7700263
- By:
- Publication type:
- Article
8
Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional models.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1529, doi. 10.1038/sj.cgt.7700264
- By:
- Publication type:
- Article
9
The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1537, doi. 10.1038/sj.cgt.7700266
- By:
- Publication type:
- Article
10
Heat-directed gene targeting of adenoviral vectors to tumor cells.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1566, doi. 10.1038/sj.cgt.7700267
- By:
- Publication type:
- Article
11
The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1543, doi. 10.1038/sj.cgt.7700268
- By:
- Publication type:
- Article
12
A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1511, doi. 10.1038/sj.cgt.7700269
- By:
- Publication type:
- Article
13
Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 12, p. 1557, doi. 10.1038/sj.cgt.7700273
- By:
- Publication type:
- Article
14
Induced p21<sup>WAF1</sup> expression acts to reverse myc myelomonocytic cell transformation.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1491, doi. 10.1038/sj.cgt.7700229
- By:
- Publication type:
- Article
15
Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1426, doi. 10.1038/sj.cgt.7700240
- By:
- Publication type:
- Article
16
Gene therapy of established mesothelioma xenografts with recombinant p16<sup>INK4a</sup> adenovirus.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1421, doi. 10.1038/sj.cgt.7700241
- By:
- Publication type:
- Article
17
The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1456, doi. 10.1038/sj.cgt.7700250
- By:
- Publication type:
- Article
18
Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1481, doi. 10.1038/sj.cgt.7700251
- By:
- Publication type:
- Article
19
Evaluation of combined vaccinia virus–mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1437, doi. 10.1038/sj.cgt.7700252
- By:
- Publication type:
- Article
20
Increase in proliferation rate and normalization of TNF-α secretion by blockage of gene transfer–induced apoptosis in lymphocytes using low-dose cyclosporine A.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1411, doi. 10.1038/sj.cgt.7700256
- By:
- Publication type:
- Article
21
Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1469, doi. 10.1038/sj.cgt.7700257
- By:
- Publication type:
- Article
22
Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1414, doi. 10.1038/sj.cgt.7700258
- By:
- Publication type:
- Article
23
Murine tyrosinase expressed by a T7 vector in bone marrow–derived dendritic progenitors effectively prevents and eradicates melanoma tumors in mice.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1448, doi. 10.1038/sj.cgt.7700260
- By:
- Publication type:
- Article
24
Third International Society of Cancer Gene Therapy Meeting.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1375, doi. 10.1038/sj.cgt.0999
- Publication type:
- Article
25
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1β induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1365, doi. 10.1038/sj.cgt.0242
- By:
- Publication type:
- Article
26
Third International Society of Cancer Gene Therapy Meeting.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1375, doi. 10.1038/sj.cgt.0999
- Publication type:
- Article
27
Abstracts of Oral Presentations and Invited Lectures.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1380, doi. 10.1038/sj.cgt.7700297
- Publication type:
- Article
28
In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1336, doi. 10.1038/sj.cgt.0237
- By:
- Publication type:
- Article
29
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1β induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1365, doi. 10.1038/sj.cgt.0242
- By:
- Publication type:
- Article
30
IκBα gene therapy in tumor necrosis factor-α- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1315, doi. 10.1038/sj.cgt.0241
- By:
- Publication type:
- Article
31
Abstracts of Poster Discussions.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1390, doi. 10.1038/sj.cgt.0777
- Publication type:
- Article
32
Induction of protective immunity against syngeneic rat cancer cells by expression of the cytosine deaminase suicide gene.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1357, doi. 10.1038/sj.cgt.0244
- By:
- Publication type:
- Article
33
A novel strategy for cancer therapy by mutated mammalian degenerin gene transfer.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1341, doi. 10.1038/sj.cgt.0239
- By:
- Publication type:
- Article
34
In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrug.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1348, doi. 10.1038/sj.cgt.0238
- By:
- Publication type:
- Article
35
Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1307, doi. 10.1038/sj.cgt.0243
- By:
- Publication type:
- Article
36
Long-term follow-up of retroviral vector-administered interferon-γ (IFN-γ) gene in metastatic melanoma.
- Published in:
- 2000
- By:
- Publication type:
- Letter
37
Nitric oxide-mediated tumor cell killing of cisplatin-based interferon-γ gene therapy in murine ovarian carcinoma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1324, doi. 10.1038/sj.cgt.0235
- By:
- Publication type:
- Article
38
Enhancement of adenoviral transduction with polycationic liposomes in vivo.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1329, doi. 10.1038/sj.cgt.0236
- By:
- Publication type:
- Article
39
Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1299, doi. 10.1038/sj.cgt.0234
- By:
- Publication type:
- Article
40
Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1299, doi. 10.1038/sj.cgt.0234
- By:
- Publication type:
- Article
41
Enhancement of adenoviral transduction with polycationic liposomes in vivo.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1329, doi. 10.1038/sj.cgt.0236
- By:
- Publication type:
- Article
42
Nitric oxide-mediated tumor cell killing of cisplatin-based interferon-γ gene therapy in murine ovarian carcinoma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1324, doi. 10.1038/sj.cgt.0235
- By:
- Publication type:
- Article
43
Long-term follow-up of retroviral vector-administered interferon-γ (IFN-γ) gene in metastatic melanoma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1297, doi. 10.1038/sj.cgt.0240
- By:
- Publication type:
- Article
44
Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1307, doi. 10.1038/sj.cgt.0243
- By:
- Publication type:
- Article
45
In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrug.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1348, doi. 10.1038/sj.cgt.0238
- By:
- Publication type:
- Article
46
In vivo tumor delivery of the green fluorescent protein gene to report future occurrence of metastasis.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1336, doi. 10.1038/sj.cgt.0237
- By:
- Publication type:
- Article
47
Induction of protective immunity against syngeneic rat cancer cells by expression of the cytosine deaminase suicide gene.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1357, doi. 10.1038/sj.cgt.0244
- By:
- Publication type:
- Article
48
ABSTRACTS OF POSTER DISCUSSIONS.
- Published in:
- 2000
- Publication type:
- Abstract
49
Third International Society of Cancer Gene Therapy Meeting.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 10, p. 1375, doi. 10.1038/sj.cgt.0999
- Publication type:
- Article
50
Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 9, p. 1241, doi. 10.1038/sj.cgt.7700219
- By:
- Publication type:
- Article